Pharma & Biotech

For investors seeking growth, the global healthcare sector continues to present compelling opportunities. The Polar Capital Global Healthcare investment trust...

The future trajectory of BioNTech SE is becoming increasingly tied to a single, promising oncology asset. The company’s ambitious cancer...

Ocugen, Inc. has bolstered its balance sheet without initiating a new formal funding round. The capital infusion came via the...

Positive early-stage clinical data for its immunotherapy drug Anktiva, presented by the company's founder, provided a pre-market lift to ImmunityBio...

A significant update to U.S. cancer treatment protocols has substantially broadened the potential patient population for ImmunityBio's flagship immunotherapy. The...

Precision Biosciences is progressing its gene therapy candidate for Duchenne muscular dystrophy (DMD), with investor attention now turning to a...

The biotechnology firm Codexis is transitioning its operations from a research-focused phase to establishing industrial production capabilities. Central to this...

The biotechnology firm Allogene Therapeutics is approaching a critical juncture that will test the long-term viability of its business model....

Biotechnology firm Xilio Development is set to present new preclinical findings for its drug candidate XTX601 at the upcoming American...

New clinical data presented this week by Arvinas at a specialist conference in Copenhagen has marked a significant advance for...